In our three-part series -- Fighting For Hope: Pediatric Cancer's Funding Crisis -- 3News' Maureen Kyle follows the journey of young patients and their families as they navigate pediatric cancer. This ...
CHICAGO and FORT WORTH, Texas, July 17, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on ...
The favorable efficacy and tolerability have inspired hope that this agent could make a difference in patients who have a ...
Ewing sarcoma is a rare and serious diagnosis, largely impacting children. The disease only accounts for about 1% of all pediatric cancers in the U.S., with about 250 children diagnosed every year, ...
Actuate Therapeutics, Inc. has announced the completion of the Phase 1 study evaluating its drug elraglusib in pediatric patients with refractory malignancies, specifically Ewing Sarcoma (EWS). The ...
Small blue round cells of Ewing Sarcoma. Nat Pernick, CC BY 3.0, via Wikimedia Commons Ewing sarcoma is one of the most common bone cancers seen in children, and if it spreads, it can be deadly. A ...
Ewing sarcoma is one of the most common bone cancers seen in children, and if it spreads, it can be deadly. One study found that under a quarter of children with multi-metastatic Ewing sarcoma ...
Dan and Sophia Lanning hosted the inaugural Sam Day Classic on Wednesday morning at the Eugene Country Club, helping raise ...
The MarketWatch News Department was not involved in the creation of this content. Los Angeles, California--(Newsfile Corp. - August 28, 2025) - In a powerful act of unity and determination, five ...
Ewing sarcoma is a type of bone cancer. However, it can also begin outside of the bones in the body’s soft tissues. In some cases, Ewing sarcoma may begin in the soft tissues and muscles rather than ...
Symptoms of Ewing sarcoma include a visible lump that develops at the tumor site. Other symptoms include a low yet consistent fever, unexplained weight loss, and anemia. This article looks at the ...